Equities

Amdocs Ltd

Amdocs Ltd

Actions
TechnologyTechnology
  • Price (EUR)83.78
  • Today's Change0.78 / 0.94%
  • Shares traded5.00
  • 1 Year change+9.15%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Amdocs Ltd had little change in net income (from 549.50m to 540.71m) despite revenues that grew 6.79% from 4.58bn to 4.89bn. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 11.55% to 11.68%.
Gross margin35.22%
Net profit margin10.27%
Operating margin13.14%
Return on assets7.91%
Return on equity14.04%
Return on investment10.21%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Amdocs Ltd fell by 53.30m. However, the company earned 822.63m from its operations for a Cash Flow Margin of 16.83%. In addition the company used 224.50m on investing activities and also paid 651.43m in financing cash flows.
Cash flow per share6.11
Price/Cash flow per share14.97
Book value per share30.69
Tangible book value per share4.24
More ▼

Balance sheet in USDView more

Amdocs Ltd has a Debt to Total Capital ratio of 15.41%, a lower figure than the previous year's 17.89%.
Current ratio1.24
Quick ratio--
Total debt/total equity0.1844
Total debt/total capital0.1541
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)1.88%
Div growth rate (5 year)12.05%
Payout ratio (TTM)42.45%
EPS growth(5 years)12.31
EPS (TTM) vs
TTM 1 year ago
-8.34
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.